Research study Program year 2019 Source: CMS Open Payments

Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)

ClinicalTrials.gov NCT03237481

Research payments

$53,403

4 payments

Through program year 2019, $53,403 in research payments was reported against Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2), across 4 payments, paid by Heron Therapeutics, Inc..

Paid by: Heron Therapeutics, Inc.
ClinicalTrials.gov: NCT03237481

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$53,403	4

Breakdown

Who paid Research payments · program year 2019

Heron Therapeutics, Inc. $53,403 4 payments

Who received the money Research payments · program year 2019

Lotus Clinical Research, LLC Organisation paid for research $51,878 1 payment
Epic Medical Research Organisation paid for research $750 1 payment
Bbcr Holdings Llc Organisation paid for research $525 1 payment
Yale-New Haven Hospital Teaching hospital · CT $250 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

4 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.